Concepedia

Emily J. Reinhard

EJ

Statistics

Publications

16

Citations

935

H-Index

13

Active since

1987

Affiliations

Monsanto (United States)(Current)

Pfizer (United States)

University of Missouri–St. Louis

Office of Science

Emily J. Reinhard is an author at Monsanto (United States) specializing in pharmacology, medicinal chemistry, and molecular pharmacology.

Publications per year

1987–2011

16

Publications

16

Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)

David R. Anderson, Shridhar G. Hegde, Emily J. Reinhard et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 265 citations · Full text

, , +10

Selective Cyclooxygenase Inhibitors: Novel 1,2-Diarylcyclopentenes Are Potent and Orally Active COX-2 Inhibitors

David B. Reitz, James J. Li, Monica B. Norton et al. · Journal of Medicinal Chemistry · 1994 · 118 citations · Full text

, , +7

Novel Terphenyls as Selective Cyclooxygenase-2 Inhibitors and Orally Active Anti-inflammatory Agents

James J. Li, Monica B. Norton, Emily J. Reinhard et al. · Journal of Medicinal Chemistry · 1996 · 107 citations · Full text

, , +12

Conformational restriction of angiotensin II: cyclic analogs having high potency

Kerry L. Spear, Emily J. Reinhard, Ellen G. McMahon et al. · Journal of Medicinal Chemistry · 1990 · 80 citations · Full text

, , +6

Diarylspiro[2.4]heptenes as Orally Active, Highly Selective Cyclooxygenase-2 Inhibitors:  Synthesis and Structure−Activity Relationships

H. T. Huang, James J. Li, Danny J. Garland et al. · Journal of Medicinal Chemistry · 1996 · 58 citations · Full text

, , +13

1–5 of 16